Summary
We studied antibodies to rheumatoid arthritis nuclear antigen (RANA) by the Ouchterlony method in 0.5% agarose plates, using soluble antigen extracted with 0.25 M sucrose solution from cultured Raji cells. Anti-RANA antibody was found in sera from 24 to 40 (60%) patients with rheumatoid arthritis (RA), from 4 of 20 (20%) patients with systemic lupus erythematosus (SLE), and from 2 of 30 (7%) healthy controls. When sucrose extracts from BJAB, Ramos, and JM cells were used as the cellular antigens, no anti-RANA precipitin lines were detected. Indirect immunofluorescence study, using Raji cells or human B lymphocytes transformed by EB virus as substrate tissues, demonstrated anti-RANA antibody as fine speckled nuclear staining. Although RA patients with positive anti-RANA antibody usually had high titers of anti-Epstein-Barr nuclear antigen (EBNA) and anti-viral capsid antigen (VCA) IgG antibodies, the Wilcoxon ranks sum test showed no close statistical correlation between the presence of anti-RANA antibodies and the titers of anti-EBNA or anti-VCA (IgG) antibodies. These data showed that the incidence of positivity of anti-RANA antibodies in Japanese RA patients is almost the same as that in American and European RA patients.
Similar content being viewed by others
References
Alspaugh MA, Tan EM (1975) Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest 55:1067–1073
Alspaugh MA, Tan EM (1976) Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Arthritis Rheum 19:711–719
Alspaugh MA, Buchanan WW, Whaley K (1978) Precipitating antibodies to cellular antigens in Sjögren's syndrome, rheumatoid arthritis, and other organ and nonorganspecific autoimmune diseases. Ann Rheum Dis 37:244–246
Alspaugh MA, Jensen FC, Rabin H, Tan EM (1978) Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis. J Exp Med 147:1018–1027
Alspaugh MA, Henle G, Lennette EL, Henle W (1981) Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest 67:1134–1140
Catalano MA, Carson DA, Slovin SF, Richman DD, Vaughan FH (1979) Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. Proc Natl Acad Sci USA 76:5825–5828
Ng KC, Brown KA, Perry JD, Holborow EJ (1980) Anti-RANA antibody: A marker for seronegative and seropositive rheumatoid arthritis. Lancet I:447–449
Ferrell PB, Aitcheson CT, Pearson GR, Tan EM (1981) Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. J Clin Invest 67:681–687
Venables PJW, Roffe LM, Erhard CC, Maini RN, Edwards JMB, Porter AD (1981) Titers of antibodies to RANA in rheumatoid arthritis and normal sera. Relationship to Epstein-Barr virus infection. Arthritis Rheum 24:1459–1464
Furuta Y (1982) Antibodies to rheumatoid arthritis nuclear antigen (RANA) in patients with collagen diseases, sicca complex and in normal subjects. Okayama Igakkai Zasshi 94:519–529
Nilsson K (1979) The nature of lymphoid cell lines and their relationship to the virus. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 227–281
Westgard JO, Lahmeyer BL (1972) Comparison of results from the Dupont “ACA” and Technicon “SMA 12/60”. Clin Chem 18:340–348
Miller G, Lipman M (1973) Release of infectious Epstein-Barr virus by transformed marmoset leucoytes. Proc Natl Acad Sci USA 70:190–194
Takada M, Murata M, Takei M, Nakagawa S, Okumura H, Kawamura A (1979) The rescue of Epstein-Barr virus from primary cultured cells of nasopharyngeal carcinoma. Comp Immunol Microbiol Infect Dis 2:177–189
Reedman BM, Klein G (1973) Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11:499–520
Henle G, Henle W (1966) Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol 91:1248–1256
Dahl JL, Hokin LE (1974) The sodium-potassium adenosinetriphosphatase. Annu Rev Biochem 43:327–356
Rosen A, Gergely P, Jondal M, Klein G (1977) Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature 267:52–54
Slaughter L, Carson DA, Jensen FC, Holbrook TL, Vaughan JH (1978) In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects. J Exp Med 148:1429–1434
Bardwick PA, Bluestein HG, Zvaifler NJ, Depper JM, Seegmiller JE (1980) Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells. Arthritis Rheum 23:626–632
Tosato G, Steinberg AD, Blease RM (1981) Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med 19:1238–1243
Catalano MA, Carson DA, Niederman JC, Feorino P, Vaughan JH (1980) Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection. J Clin Invest 65:1238–1242
Catalano MA, Slovin SF, Freer SS (1980) Anti-RANA antibody and rheumatoid arthritis. Lancet 1:824
Venables PJW, Maini RN (1980) Antibodies to RANA and other nuclear antigens in infectious mononucleosis (IM) and rheumatoid arthritis (RA). Ann Rheum Dis 39:191
Hinuma Y, Ohta-Hatano R, Suto T, Numazaki Y (1969) High incidence of Japanese infants with antibody to a herpes-type virus associated with cultured Burkitt lymphoma cells. Jpn J Microbiol 13:309–311
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakabayashi, K., Saito, M., Nagasawa, T. et al. Antibodies to rheumatoid arthritis nuclear antigen (RANA) in Japanese patients with rheumatoid arthritis. Rheumatol Int 5, 61–67 (1985). https://doi.org/10.1007/BF00270298
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00270298